---

Cloning and characterization of alpha-amylase from a clinical isolate of staphylococcus aureus resistant to vancomycin

---

Original Article

Author Details : V L Asha Latha*, B Sushma, P V G K Sharma

Volume : 7, Issue : 2, Year : 2020

Article Page : 247-250

https://doi.org/10.18231/j.ijcbr.2020.053

Suggest article by email

Get Permission

---

Abstract

Introduction: Staphylococcus aureus (S. aureus) is one of the prominent gram positive human pathogen
secretes many surface and secretary proteins including various enzymes and pathogenic factors that favour
the colonization and infection of host tissue. Alpha-amylase is one of the enzymes secreted by S.aureus
which catalyses the breakdown of complex sugars to monosaccharides, which are required for colonization
and survival of this pathogen.
Materials and Methods: In the present study we have cloned, sequenced, expressed and characterized
a-amylase from the clinical isolate of S.aureus resistant to vancomycin (VRSA). The 25kb plasma DNA
was isolated from the clinical isolate of S.aureus and a 600bp PCR amplified product was obtained.
Results: The SDS-PAGE analysis of induced and un-induced clone SB3 indicates that a-amylase has a
M.W. of 22KD. The ra-amylase was eluted from the gel and enzymes assay was performed. The Km was
found to be close to Km of native a-amylase identified in the extracellular and in the cytosolic fraction of
S.aureus resistant to vancomycin.
Conclusion: The current study clearly indicate that there is clear distinction between the a-amylase of
human and different prokaryotes, particularly S.aureus which made this enzyme an ideal target in the
development of drugs against infections of tooth and oral cavities.

Keywords: Staphylococcus aureus, Alpha-amylase, Cloning, Vancomycin.

How to cite : Latha V L A, Sushma B , Sharma P V G K, Cloning and characterization of alpha-amylase from a clinical isolate of staphylococcus aureus resistant to vancomycin. Int J Clin Biochem Res 2020;7(2):247-250

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.